钙拮抗剂：仍适合作为一线抗高血压药物。 - Suppr

Suppr

超能文献

Calcium antagonists: still appropriate as first line antihypertensive agents.

作者信息

Epstein M

机构信息

Department of Veterans Affairs Medical Center, University of Miami School of Medicine, Florida 33125, USA.

出版信息

Am J Hypertens. 1996 Feb;9(2):110-21. doi: 10.1016/0895-7061(96)00013-1.

DOI:10.1016/0895-7061(96)00013-1

PMID:8924260

Abstract

摘要

相似文献

Calcium antagonists: still appropriate as first line antihypertensive agents.钙拮抗剂：仍适合作为一线抗高血压药物。

Am J Hypertens. 1996 Feb;9(2):110-21. doi: 10.1016/0895-7061(96)00013-1.

Calcium antagonists "some agents lower blood pressure and still put the heart at risk"?

Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):823-34. doi: 10.3109/10641969909061012.

[Management of hypertensive patients with cardiovascular damage].[心血管损伤高血压患者的管理]

Nihon Rinsho. 2004 Mar;62 Suppl 3:612-6.

[Amlodipine].氨氯地平

Dtsch Med Wochenschr. 1998 Jan 2;123(1-2):19-20. doi: 10.1055/s-0029-1233207.

Newer calcium antagonists for treatment of systemic hypertension.用于治疗系统性高血压的新型钙拮抗剂。

J Assoc Physicians India. 1995 Apr;43(4):277-81.

[Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].

MMW Fortschr Med. 2001 Jun 21;143(25):58.

[Pharmacologic regression of cardiac and vascular structural changes in the hypertensive patient. A question that goes beyond the exclusive medical bias].[高血压患者心脏和血管结构改变的药物性逆转。一个超越单纯医学偏见的问题]

Arq Bras Cardiol. 1995 Dec;65(6):555-63.

[New central agents in the treatment of arterial hypertension].

An Med Interna. 1999 Oct;16(10):495-7.

Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.二氢吡啶类药物与其他药物治疗老年高血压的比较。第1部分：抗高血压治疗与左心室肥厚

J Hypertens Suppl. 1993 Dec;11(6):S27-9.

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.原发性高血压患者左心室肥厚的逆转。随机双盲研究的荟萃分析。

JAMA. 1996 May 15;275(19):1507-13.

引用本文的文献

Selective blockade of Ca1.2 (α1C) versus Ca1.3 (α1D) L-type calcium channels by the black mamba toxin calciseptine.黑曼巴毒素 calciseptine 对 Ca1.2（α1C）与 Ca1.3（α1D）L 型钙通道的选择性阻断。

Nat Commun. 2024 Jan 2;15(1):54. doi: 10.1038/s41467-023-43502-w.

Multi-organ dysfunction as a presentation of calcium channel blocker intoxication.钙通道阻滞剂中毒表现为多器官功能障碍。

BMJ Case Rep. 2022 Jan 17;15(1):e245711. doi: 10.1136/bcr-2021-245711.

Hypertensive Emergency in Aortic Dissection and Thoracic Aortic Aneurysm-A Review of Management.主动脉夹层和胸主动脉瘤中的高血压急症——管理综述

Pharmaceuticals (Basel). 2009 Sep 28;2(3):66-76. doi: 10.3390/ph2030066.

Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.N,N'-二取代嘧啶并三酮作为帕金森病 Ca(V)1.3 钙通道选择性拮抗剂的构效关系。

J Med Chem. 2013 Jun 13;56(11):4786-97. doi: 10.1021/jm4005048. Epub 2013 May 23.

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease. Cav1.3 选择性 L 型钙通道拮抗剂有望成为帕金森病的新型治疗药物。

Nat Commun. 2012;3:1146. doi: 10.1038/ncomms2149.

Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study.二氢吡啶类钙通道阻滞剂与老年患者的心血管结局：一项基于人群的研究。

Can J Cardiol. 2008 Aug;24(8):629-32. doi: 10.1016/s0828-282x(08)70651-2.

Differential effects of urapidil and doxazosin on heart rate.

Eur J Clin Pharmacol. 2007 Mar;63(3):259-62. doi: 10.1007/s00228-006-0256-2. Epub 2007 Jan 16.

The use of calcium antagonists in the treatment of hypertensive persons with kidney disease.

Curr Hypertens Rep. 2002 Jun;4(3):191-4. doi: 10.1007/s11906-002-0006-5.

Manidipine: a review of its use in hypertension.马尼地平：其在高血压治疗中的应用综述

Drugs. 2001;61(12):1777-99. doi: 10.2165/00003495-200161120-00010.

Role of a third generation calcium antagonist in the management of hypertension.第三代钙拮抗剂在高血压治疗中的作用。

Drugs. 1999;57 Suppl 1:1-10. doi: 10.2165/00003495-199957001-00001.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验